Advertisement
In a position statement from the North American Menopause Society

NAMS Updates Guidance for Genitourinary Syndrome of Menopause

0
GSM is underdiagnosed and undertreated, but symptoms can be managed effectively in most cases
There was widespread reporting of avoidance of medical care due to COVID-19-related concerns in June 2020

Widespread Avoidance of Medical Care Found Due to COVID-19 Concerns

0
Prevalence of care avoidance higher for caregivers, those with underlying conditions, disabilities
The rates of adults with high-grade soft tissue sarcoma who receive chemotherapy may be lower than expected

Few High-Grade Soft Tissue Sarcoma Patients Receive Chemo

0
Percentage of STS patients receiving chemo driven by factors such as tumor size, income, facility type
Current low-intensity smokers have an increased risk for respiratory and lung cancer mortality

Respiratory, Lung Cancer Death Up Even With Low-Intensity Smoking

0
Risks for respiratory and lung cancer mortality increased for those smoking <10 cigarettes per day
Use of medical marijuana is associated with fewer hospitalizations among patients with sickle cell disease

Medical Marijuana Tied to Fewer Admissions in Sickle Cell Disease

0
But no change in opioid use observed for those receiving medical marijuana certification
After adjustment for clinical and nonclinical factors

Factors Clarify Racial Disparity in Prostate Cancer Survival

0
Education, median household income, and insurance status contribute most to racial disparity in the U.S.
Use of permanent hair dye is not associated with the risk for most cancers or cancer mortality

Permanent Hair Dye Not Linked to Cancer Risk, Mortality

0
Risk increased slightly for basal cell carcinomas; positive link found for some breast cancers, ovarian cancer
In a second edition of international guidelines

Guidelines Updated for Hereditary Hemorrhagic Telangiectasia

0
Updated content covers six topic areas, including new areas of anemia, pediatrics, pregnancy and delivery
Severe hearing impairment in childhood cancer survivors is associated with neurocognitive deficits

Child Cancer Survivors’ Hearing Loss Linked to Cognitive Deficits

0
Findings seen in survivors of childhood cancer independent of the neurotoxic treatment received
For patients with stage III melanoma with BRAF V600E or V600K mutations

Benefit of Adjuvant Dabrafenib + Trametinib Persists in Melanoma

0
Long-term benefit seen for relapse-free survival in stage III disease with BRAF V600E, V600K mutations